A Guide to Fiscal Year 1991 Federal Funding for HIV Disease: How Dollars are Spent How to Access Them

for conducting AIDS-related product research and review activities. Part of this effort involves in-depth study related to cell biology, immunology and other potential keys to understanding HIV and related viruses at field laboratories. Vaccine-related research is conducted in such areas as viral immunology, pathogenesis, and molecular biology. To enhance the expeditious development of drug therapies and vaccines, the FDA advocates early consultation between scientists, reviewers, and drug and vaccine sponsors, to provide technical assistance, thorough understanding of regulations regarding phased trials and protocols, and uniformity of understanding related to priorities in treatments and therapies related to HIV disease and opportunistic infections. In addition, FDA monitors availability of nonapproved treatments and halt the marketing of fraudulent health products. FDA education efforts related to proper care and nutrition of those infected with HIV involve publications, a nutrition videotape, participation in conferences, and community-based efforts. Diagnostics The FDA is responsible for approval of diagnostics related to HIV disease. Specific and sensitive diagnostic tools are vital to the safety of the blood supply, as well as to the ability of physicians to properly diagnose and treat patients with HIV disease. While responsible for approval of accurate and effective diagnostic products, the FDA is also involved in educating manufacturers to the key issues related to manufacture and clinical evaluation of diagnostics, participates with the American Red Cross in screening programs to ensure safety of the nation's blood supply, and has established guidelines as to the type of diagnostics appropriate for use related to HIV disease. For example, FDA policy has established that home test kits for AIDS will not be approved, while accurate rapid diagnostic screens for HIV used in medical settings will be approved. Medical Devices FDA launched a program focused on preventing transmission of HIV and AIDS-related diseases through such barrier products as condoms, surgical gloves, and commonly-used clinical devices. The FDA conducts research on effectiveness of condoms in preventing HIV transmission, as well as studies on environmental factors related to improving effectiveness. FDA inspects manufactured products regularly to ensure compliance with its criteria for acceptability. The FDA published a brochure promoting condom use in respect to HIV disease. In the same way, FDA regulates manufacturing practices related to production of latex and vinyl gloves. Along with regular compliance inspections, FDA is conducting research related to development of more effective barrier protection. Sterilization and disinfection practices related to medical devices used in the health-care environment is also under study. FDA is exploring ways manufacturers' products can be more easily sterilized, as well as ways to improve sterilization and disinfecting procedures. No FDA HIV funds are available for competitive applications. From time to time the FDA does issue contracts for specific services, however they are not normally handled through a competitive process. For further information related to FDA HIVrelated programs and activities contact: Randolph F. Wycoff, M.D. M.P.H. Director AIDS Coordination Staff FDA Parklawn Bldg, Rm. 12A-40 Rockville, MD 20857 301/443-0104 SGENCY FOR HEALTH CARE POLICY RESEARCH The Agency for Health Care Policy Research (AHCPR), formerly the National Center for Health Care Services Research and Health Care Technology Assessment (NCHSR), has a broad legislative mandate to support general health services research on problems related to the organization, financing, quality, and delivery of health services. AHCPR's goal is to enhance the quality, appropriateness, and effectiveness of health care services, and access to such services through the establishment of a broad 72 Reproduction By Permission Only ~1991 ASAP 72 Reproduction By Permission Only ~1991 ASAP

/ 126
Pages

Actions

file_download Download Options Download this page PDF - Pages 49-98 Image - Page 72 Plain Text - Page 72

About this Item

Title
A Guide to Fiscal Year 1991 Federal Funding for HIV Disease: How Dollars are Spent How to Access Them
Author
Americans for a Sound AIDS/HIV Policy
Canvas
Page 72
Publication
Americans for a Sound AIDS/HIV Policy
1991
Subject terms
reports
Item type:
reports

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0036.004
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0036.004/74

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0036.004

Cite this Item

Full citation
"A Guide to Fiscal Year 1991 Federal Funding for HIV Disease: How Dollars are Spent How to Access Them." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0036.004. University of Michigan Library Digital Collections. Accessed June 3, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel